Can Oxymetazoline (Afrin) cause nasal dryness?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Yes, Afrin (oxymetazoline) can cause nasal dryness as a side effect. Afrin is a topical decongestant nasal spray that works by constricting blood vessels in the nasal passages, which reduces swelling and congestion. While it effectively relieves nasal congestion in the short term, it can lead to dryness of the nasal mucosa with regular use, as noted in a study published in 2020 1. This dryness occurs because the medication reduces blood flow to the nasal tissues, which can decrease natural moisture production.

Key Considerations

  • Afrin should only be used for a maximum of 3 consecutive days to avoid rebound congestion (rhinitis medicamentosa), where nasal congestion worsens after the medication wears off, as recommended by the package insert for oxymetazoline nasal spray 1.
  • If you're experiencing nasal dryness while using Afrin, consider alternatives like saline nasal sprays to moisturize the nasal passages, or consult with a healthcare provider about other decongestant options.
  • For chronic nasal congestion, it's better to address the underlying cause rather than relying on Afrin long-term, as regular use can lead to rhinitis medicamentosa, a condition characterized by rebound nasal congestion, as discussed in a study published in 2008 1.

Potential Risks and Alternatives

  • Topical decongestants like Afrin can cause local stinging or burning, sneezing, and dryness of the nose and throat, as reported in a study published in 2008 1.
  • Patients with certain medical conditions, such as hypertension, glaucoma, or hyperthyroidism, should use Afrin with caution, as it can exacerbate these conditions, as noted in a study published in 2008 1.
  • Saline nasal sprays or other moisturizing agents can help alleviate nasal dryness and congestion without the risk of rebound congestion associated with Afrin, as suggested by a study published in 2020 1.

From the FDA Drug Label

When using this product Frequent or prolonged use may cause nasal congestion to recur or worsen temporary discomfort such as burning, stinging, sneezing or an increase in nasal discharge may occur The answer to whether afrin (oxymetazoline) can cause nasal dryness is not directly stated in the label.

  • Nasal dryness is not mentioned in the label.
  • The label does mention temporary discomfort and nasal discharge, but not dryness. 2

From the Research

Nasal Dryness and Afrin

  • Afrin, also known as oxymetazoline, is a nasal decongestant that can provide rapid relief of nasal obstruction [(3,4,5)].
  • The studies provided do not directly address the question of whether Afrin can cause nasal dryness [(3,4,5)].
  • However, it is known that long-term use of oxymetazoline can lead to rebound congestion, also known as rhinitis medicamentosa, which may be associated with nasal dryness 5.
  • One study found that oxymetazoline was not associated with rebound congestion or tachyphylaxis when used for four weeks in normal subjects 3.
  • Another study found that the combination of oxymetazoline and intranasal steroid was effective in reducing nasal congestion in patients with chronic rhinitis, without inducing rhinitis medicamentosa 4.
  • A case report described a patient who developed a severe oxymetazoline use disorder, which may be related to the drug's potential to cause rebound congestion and nasal dryness 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.